Biogen Revenue Down as Multiple Sclerosis Sales Slide

Date:




Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Marvel-themed theater cups, buckets recalled over batteries

Marvel-themed products sold at movie theaters recalled over battery...

Opinion | Hollywood’s Rule of Lawfare

Attorneys general wield antitrust law as a weapon against...

Israel says it has serious concerns with Hamas disarmament deal

TEL AVIV, Israel -- Israel has shared “serious security...